TMCnet - World's Largest Communications and Technology Community



Research and Markets: Genes and Patents: Evolution; Controversies and Perspectives (Technical Insights)
[July 04, 2014]

Research and Markets: Genes and Patents: Evolution; Controversies and Perspectives (Technical Insights)

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Genes and Patents: Evolution; Controversies and Perspectives (Technical Insights)" report to their offering.

Genes are the constituent elements of a human body. Genetic research has been carried out to find answers to several questions pertaining to diseases, drug discovery, diagnostics and therapeutics. It is an expensive mode of research and development. As a result, many researchers and developers see the need to secure intellectual property protection by means of patents.

This not only secures theirexpensive invention from being duplicated elsewhere but also provides collateral for funding. But genetic patenting has been in news for quite some time. For many, it is difficult to fathom how a third party can claim ownership over ones genes. Moreover, patenting restricts access to knowledge which in turn provides a setback to the research community. In the light of the above mentioned, the United States Supreme Court deliberated on the celebrated case of Association for Molecular Pathology v. Myriad Genetics. The decision changed to quite an extent the patent eligibility requirements for a naturally occurring gene. It left several previously granted patents vulnerable to be invalidated. The United States Patent and Trademarks Office laid down guidelines for examination of such patent applications, post this decision.

The research service highlights such details in the field of gene patenting.

Key Topics Covered:

- Research Scope

- Benefits of Gene Patenting

- History of Genes and Gene Patenting

- Statistics

- Standards of Gene Patentability

- Issues Regarding Gene Patenting

- Gene Patents and Bioethics

- Understanding Association For Molecular Pathology v. Myriad Genetics

- Aftermath of The Myriad Ruling

- Key Findings

- The publisher's story

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy